Fabtech Technologies, a biopharma engineering solutions provider, launched its Rs 230 crore IPO on September 29, closing October 1, with a price band of Rs 181-191. The issue is attracting strong grey market interest, indicating an 18% listing gain expectation. Proceeds will fund working capital and acquisitions, bolstering its robust financial performance and diversified order book.
Sebi board meeting: PMS rules overhaul, FPI commodity trades among key decisions to watch out
Sebi’s upcoming board meeting aims to discuss significant changes to portfolio management services and settlement regulations. Proposed revisions could allow discretionary portfolio managers to make